FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480931715> ?p ?o ?g. }

• W1480931715 endingPage "891" @default.
• W1480931715 startingPage "883" @default.
• W1480931715 abstract "Determination of ASO and other serum antibodies to extracellular antigens has been widely employed for the diagnosis of infection of hemolytic streptococcus.A new laboratory microtiter technique for determining antibodies to a bacterial somatic component (anti-streptococcal-polysaccharide (ASP)) has been developed.This technique permits an easy detection of antibodies to C polysaccharide that is a component of the cell wall of Group A hemolytic streptococcus.The present study was designed to evaluate diagnostic value of ASP determination.Serum samples were obtained from 538 children aged between 6 and 15 years (patients in Osaka municipal children's hospital and elementary school children in Osaka City) from April, 1979 to January, 1983 and serum ASP, ASO and ASK titers were determined.The mean ASP level was 1: 64 for the age group between 6 and 9 years, 1: 43, between 10 and 12 years, and 1: 50, between 13 and 15 years, and the cutoff value between a normal and an abnormal level would be between 1: 32 and 1: 64.The coefficents of correlation was 0.214 between ASP and ASO, 0.103 between ASP and ASK, and 0.705 between ASO and ASK, which indicated that ASO and ASK had the most correlative, value.Clinical isolates were obtained from a throat of 109 elementary school children in Osaka City six times over the period of one year and the relationship between Group A hemolytic streptococcus and titers of these antibodies was studied.The proportion of cases with elevated titers increased in all antibodies as the incidence of positive bacterial cultures increased.Of 50 patients from whom Group A hemolytic streptococcus isolated at least once, 23 (46.0%) showed elevations in ASO and ASK titers but only 18 (36.0%) had elevation in ASP titer.Among 28 children with normal ASO titer of below 1: 240 despite a positive bacterial culture, the numbers of cases with elevated ASP and ASK levels were 10 (38.5%) and 7 (25.0%), respectively.The determination of ASP was slightly more beneficial for the diagnosis of infections with Group A hemolytic streptococcus." @default.
• W1480931715 created "2016-06-24" @default.
• W1480931715 creator A5052407542 @default.
• W1480931715 creator A5061291083 @default.
• W1480931715 creator A5086960018 @default.
• W1480931715 creator A5087076400 @default.
• W1480931715 date "1985-01-01" @default.
• W1480931715 modified "2023-10-04" @default.
• W1480931715 title "A Study on Serum Titers of Anti-Streptococcal Polysaccharide (ASP) Among School Children" @default.
• W1480931715 cites W1599132982 @default.
• W1480931715 cites W1941432970 @default.
• W1480931715 cites W1978160979 @default.
• W1480931715 cites W1978720731 @default.
• W1480931715 cites W2002499849 @default.
• W1480931715 cites W2115583525 @default.
• W1480931715 doi "https://doi.org/10.11150/kansenshogakuzasshi1970.59.883" @default.
• W1480931715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3935732" @default.
• W1480931715 hasPublicationYear "1985" @default.
• W1480931715 type Work @default.
• W1480931715 sameAs 1480931715 @default.
• W1480931715 citedByCount "0" @default.
• W1480931715 crossrefType "journal-article" @default.
• W1480931715 hasAuthorship W1480931715A5052407542 @default.
• W1480931715 hasAuthorship W1480931715A5061291083 @default.
• W1480931715 hasAuthorship W1480931715A5086960018 @default.
• W1480931715 hasAuthorship W1480931715A5087076400 @default.
• W1480931715 hasBestOaLocation W14809317151 @default.
• W1480931715 hasConcept C126322002 @default.
• W1480931715 hasConcept C147483822 @default.
• W1480931715 hasConcept C159654299 @default.
• W1480931715 hasConcept C203014093 @default.
• W1480931715 hasConcept C22889606 @default.
• W1480931715 hasConcept C2778276568 @default.
• W1480931715 hasConcept C2779306812 @default.
• W1480931715 hasConcept C2779489039 @default.
• W1480931715 hasConcept C32611913 @default.
• W1480931715 hasConcept C523546767 @default.
• W1480931715 hasConcept C54355233 @default.
• W1480931715 hasConcept C71924100 @default.
• W1480931715 hasConcept C86803240 @default.
• W1480931715 hasConcept C89423630 @default.
• W1480931715 hasConceptScore W1480931715C126322002 @default.
• W1480931715 hasConceptScore W1480931715C147483822 @default.
• W1480931715 hasConceptScore W1480931715C159654299 @default.
• W1480931715 hasConceptScore W1480931715C203014093 @default.
• W1480931715 hasConceptScore W1480931715C22889606 @default.
• W1480931715 hasConceptScore W1480931715C2778276568 @default.
• W1480931715 hasConceptScore W1480931715C2779306812 @default.
• W1480931715 hasConceptScore W1480931715C2779489039 @default.
• W1480931715 hasConceptScore W1480931715C32611913 @default.
• W1480931715 hasConceptScore W1480931715C523546767 @default.
• W1480931715 hasConceptScore W1480931715C54355233 @default.
• W1480931715 hasConceptScore W1480931715C71924100 @default.
• W1480931715 hasConceptScore W1480931715C86803240 @default.
• W1480931715 hasConceptScore W1480931715C89423630 @default.
• W1480931715 hasIssue "9" @default.
• W1480931715 hasLocation W14809317151 @default.
• W1480931715 hasLocation W14809317152 @default.
• W1480931715 hasOpenAccess W1480931715 @default.
• W1480931715 hasPrimaryLocation W14809317151 @default.
• W1480931715 hasRelatedWork W1539989077 @default.
• W1480931715 hasRelatedWork W1573622384 @default.
• W1480931715 hasRelatedWork W1982243748 @default.
• W1480931715 hasRelatedWork W2013245643 @default.
• W1480931715 hasRelatedWork W2018354288 @default.
• W1480931715 hasRelatedWork W2097426290 @default.
• W1480931715 hasRelatedWork W2148908215 @default.
• W1480931715 hasRelatedWork W2400040201 @default.
• W1480931715 hasRelatedWork W2427966752 @default.
• W1480931715 hasRelatedWork W99623130 @default.
• W1480931715 hasVolume "59" @default.
• W1480931715 isParatext "false" @default.
• W1480931715 isRetracted "false" @default.
• W1480931715 magId "1480931715" @default.
• W1480931715 workType "article" @default.